Androgenetic alopecia (AGA), also known as male- and female-pattern hair loss, is a common condition affecting both men and women. Various factors contribute to androgenic alopecia, including age, medications, underlying health conditions, and genetics.

There are two main objectives when treating AGA with platelet-rich fibrin: first, to stimulate dormant hair follicles, and second, to promote the formation of blood vessels around these follicles. This process improves the supply of nutrients and enhances cellular activity. When combined, these actions can lead to increased hair density, thickness, and overall scalp health.